Recent advances and future perspectives of CAR-T cell therapy in head and neck cancer

Head and neck cancer (HNC) ranks as the sixth most prevalent type of cancer globally and accounts for about 4% of all types of cancer. Among all HNC, most are head and neck squamous cell carcinoma (HNSCC) with clinical therapies that include surgery, radiation therapy, chemotherapy, immunotherapy, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Chunmei, Liu, Min, Li, Yutao, Zhao, Yi, Sharma, Amit, Liu, Haotian, Schmidt-Wolf, Ingo G. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10346844/
https://www.ncbi.nlm.nih.gov/pubmed/37457699
http://dx.doi.org/10.3389/fimmu.2023.1213716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10346844/
https://www.ncbi.nlm.nih.gov/pubmed/37457699
http://dx.doi.org/10.3389/fimmu.2023.1213716

Ejemplares similares